EBV-VCA ANTIBODY (IGG)

Antiserum, Cf, Epstein-barr Virus

HILLCREST BIOLOGICALS

The following data is part of a premarket notification filed by Hillcrest Biologicals with the FDA for Ebv-vca Antibody (igg).

Pre-market Notification Details

Device IDK884591
510k NumberK884591
Device Name:EBV-VCA ANTIBODY (IGG)
ClassificationAntiserum, Cf, Epstein-barr Virus
Applicant HILLCREST BIOLOGICALS 10703 PROGRESS WAY Cypress,  CA  90630
ContactCarolyn B Wagner
CorrespondentCarolyn B Wagner
HILLCREST BIOLOGICALS 10703 PROGRESS WAY Cypress,  CA  90630
Product CodeGNP  
CFR Regulation Number866.3235 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1988-11-03
Decision Date1989-01-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.